x |
| Neurocrine Biosciences Experiencing Revenue Downtrend While its Industry is in an Uptrend |
|
Stock Quote: (NasdaqNM:NBIX) |
| 11/09/2009 |
|
| 5.68 |
+0.26 |
+4.80% |
469,333 |
|
| Neurocrine Biosciences Experiencing Revenue Downtrend While its Industry is in an Uptrend |
|
| Last |
Price Change |
% Chg |
Volume |
|
|
New York, New York, November 9, 2009,T12-NEWS reports that Revenue for Neurocrine Biosciences (NASDAQ:NBIX) for its trailing twelve months (TTM) ended September 30, 2009 decreased by -22.13% to $2,942 ... read full story |
|
|
|